Market closedNon-fractional
OptimizeRx/OPRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About OptimizeRx
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Ticker
OPRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
Waltham, United States
Employees
136
Website
www.optimizerx.com
OptimizeRx Metrics
BasicAdvanced
$195M
Market cap
-
P/E ratio
-$1.05
EPS
1.05
Beta
-
Dividend rate
Price and volume
Market cap
$195M
Beta
1.05
Financial strength
Current ratio
2.884
Quick ratio
2.741
Long term debt to equity
26.708
Total debt to equity
29.754
Interest coverage (TTM)
-3.73%
Management effectiveness
Return on assets (TTM)
-4.54%
Return on equity (TTM)
-14.66%
Valuation
Price to revenue (TTM)
2.38
Price to book
1.61
Price to tangible book (TTM)
-45.95
Price to free cash flow (TTM)
-31.887
Growth
Revenue change (TTM)
26.71%
Earnings per share change (TTM)
30.88%
3-year revenue growth (CAGR)
18.54%
3-year earnings per share growth (CAGR)
186.53%
What the Analysts think about OptimizeRx
Analyst Ratings
Majority rating from 7 analysts.
OptimizeRx Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$20M
-30.74%
Net income
-$6.8M
65.85%
Profit margin
-34.69%
139.57%
OptimizeRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.01
$0.09
$0.26
-$0.11
-
Expected
-$0.02
$0.03
$0.32
-$0.13
-$0.05
Surprise
-53.33%
260.00%
-19.50%
-13.73%
-
OptimizeRx News
AllArticlesVideos
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
GlobeNewsWire·2 days ago
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
GlobeNewsWire·4 days ago
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OptimizeRx stock?
OptimizeRx (OPRX) has a market cap of $195M as of July 27, 2024.
What is the P/E ratio for OptimizeRx stock?
The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of July 27, 2024.
Does OptimizeRx stock pay dividends?
No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next OptimizeRx dividend payment date?
OptimizeRx (OPRX) stock does not pay dividends to its shareholders.
What is the beta indicator for OptimizeRx?
OptimizeRx (OPRX) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell OptimizeRx stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.